Why Belgium is limiting the Johnson & Johnson COVID vaccine to adults over 40 By Hannah Seo / May 27, 2021
A new Pfizer trial combines a COVID booster and pneumonia vaccine for seniors By Nikita Amir / May 24, 2021
There are more immunocompromised Americans than we think, and that’s a problem with COVID-19 vaccines By Ellie Shechet / May 21, 2021
Experts says blood clots from AstraZeneca’s COVID vaccine are rare enough to justify its use By Philip Kiefer / Apr 8, 2021
How should parents with unvaccinated kids handle the CDC’s new mask guidelines? By Marion Renault / May 18, 2021
Your questions about kids and COVID-19 vaccines, answered By Debbie-Ann Shirley/The Conversation / May 14, 2021
Fully vaccinated people no longer need to wear masks—but there’s a catch By Claire Maldarelli , Emily Cerf / May 13, 2021
The Sturgis Motorcycle Rally may account for 19 percent of US COVID-19 cases in August By Claire Maldarelli / Sep 8, 2020
The US joined the push to waive COVID-19 vaccine patents. Will it actually help? By Marion Renault / May 13, 2021
Pfizer and Moderna are studying their COVID vaccines in kids as young as 6 months By Hannah Seo / Apr 29, 2021
If you’re fully vaccinated, you (mostly) don’t need to wear a mask outdoors By Sara Chodosh / Apr 27, 2021
The CDC recommends that the Johnson & Johnson COVID vaccine resume By Claire Maldarelli / Apr 23, 2021
Regular childhood vaccinations dipped during COVID, opening a door for measles outbreaks By Philip Kiefer / Apr 23, 2021
Everyone over 16 can now get the COVID vaccine. How do we make sure they get it? By Kat Eschner / Apr 21, 2021
UK doctors will re-expose COVID-19 survivors to study how long immunity lasts By Emily Cerf / Apr 19, 2021
The pause on Johnson & Johnson’s COVID vaccine doesn’t mean it’s not safe By Hannah Seo / Apr 13, 2021
An HIV vaccine could arrive sooner than we thought—using Moderna’s mRNA tech By Hannah Seo / Apr 12, 2021
COVID’s fourth wave is on the way—and younger people could be most at risk By Nikita Amir / Apr 5, 2021
Johnson & Johnson’s vaccine blunder is a surprisingly good thing By Tinglong Dai/The Conversation / Apr 2, 2021
How to protect your privacy while signing up for a COVID-19 vaccine online By Violet Blue / Apr 1, 2021
Native American communities take the lead on vaccinations after facing staggering rates of COVID-19 By Kat Eschner / Mar 19, 2021
COVID-19 ‘vaccine passports’ could set a troubling precedent By Yara M. Asi/The Conversation / Mar 16, 2021
The FDA just authorized Johnson & Johnson’s single-shot COVID-19 vaccine By Claire Maldarelli / Feb 27, 2021
Johnson & Johnson’s COVID-19 vaccine just passed the FDA’s final test By Philip Kiefer / Feb 26, 2021
Americans spend millions of dollars on rabies treatments each year. They don’t have to. By Gustav Cappaert/Undark / Feb 25, 2021
What pregnant, breastfeeding, and prospective parents should know about the COVID-19 vaccines By Kat Eschner / Feb 22, 2021
Facing COVID-19 variants, vaccine makers are weighing how to tweak their designs By Rahul Rao / Feb 16, 2021
One big hiccup in US efforts to distribute COVID-19 vaccines? Poor internet access. By Tamra Burns Loeb, Et Al./The Conversation / Feb 10, 2021